AR	androgen receptor
CPS	combined positive score
CR	complete response
CT	computed tomography
CTCAE	common terminology criteria for adverse events
EGFR	epidermal growth factor receptor
EMPD	extramammary Paget disease
GCDFP-15	gross cystic disease fluid protein 15
H&E	hematoxylin and eosin
HER2	human epidermal growth factor receptor 2
IARC	international agency for research on cancer
ICI	immune checkpoint inhibitor
IV	intravenously
MRI	magnetic resonance imaging
MSI	microsatellite instability
MSS	microsatellite stable
PD	progressive disease
PD-(L)1	programmed death-(ligand) 1
PET-CT	positron emission tomography–computed tomography
PFS	progression-free survival
PR	partial response
RECIST	response evaluation criteria in solid tumors
SD	stable disease
SGC	sweat gland carcinoma
TKI	tyrosine kinase inhibitor
TMB	tumor mutational burden
WHO	World Health Organization